Search results
Free COVID-19 vaccines could be a thing of the past. Experts weigh in.
USA TODAY via Yahoo News· 5 days agoVaccine manufacturers Novavax and Pfizer said via email they planned to assess their accessibility...
Pfizer plans to cut costs by $1.5 billion as demand for COVID vaccine dwindles
Quartz· 5 days agoPharma giant Pfizer announced Wednesday another cost-cutting initiative as the company struggles...
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters via Yahoo Finance· 5 days agoInvestors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19 ...
Pfizer Stock: Chart Indicates a Long-Term Bottom , But Is the Dividend Safe? | Investing.com
Investing.com· 15 hours agoLooking at the lower third of PFE, you can...revenue spiked to over $100 bl by the end of 2022,...
How Much Will Pfizer Pay Out in Dividends This Year?
Motley Fool via Yahoo Finance· 1 day agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (NYSE: PFE) a household name in recent years, but this isn't all the company ...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 5 days agoShares of Novavax which makes a Covid-19 vaccine, were up 6.3%. Even vaccine stalwarts like GSK and...
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC· 5 days agoPfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to...
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 4 days agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company ...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 4 days agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
StreetInsider· 3 days agoThe European Union's regulator told vaccine makers last month to update their vaccines for that variant because they would likely be effective against its ...